Companies Cryptocurrencies
Organogenesis Holdings Inc
Organogenesis Holdings Inc
Exchange: NasdaqCM
IPO Date: 02/12/2016
CEO: Mr. Gary S. Gillheeney Sr.
Drug Manufacturers General Specialty & Generic Healthcare đź”—
  • ORGO
  • 15.42
  • 1982765312
    market cap
  • -0.18999958
If you bought

shares of Organogenesis Holdings Inc (ORGO) on
You would have made
Old Price $12 Current Price $12

Organogenesis Holdings, Inc. is a regenerative medical company. The company is headquartered in Canton, Massachusetts and currently employs 700 full-time employees. The firm focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The firm is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Address: 85 Dan Rd Canton MASSACHUSETTS 02021

Stay updated.